SAba Sile
Corporate Officer/Principal chez SPRUCE BIOSCIENCES, INC.
Postes actifs de SAba Sile
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Corporate Officer/Principal | 10/11/2022 | - |
Historique de carrière de SAba Sile
Anciens postes connus de SAba Sile
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - | - |
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | - | - |
Formation de SAba Sile
| University of Pittsburgh School of Medicine | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| Irlande | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| SPRUCE BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |